2.3 Bn Mycotoxin Testing Market Analysis by Aflatoxins, Ochratoxin, Fumonisins, Zearalenone, Deoxynivalenol, Trichothecenes, Patulin - Global Forecast to 2029

NEOG Stock  USD 12.02  0.38  3.26%   
Roughly 79 percent of all Neogen's stockholders are aggressively thinking of buying. The analysis of overall sentiment of trading Neogen stock suggests that a large number of investors are excited at this time. The current market sentiment, together with Neogen's historical and current headlines, can help investors time the market. In addition, many technical investors use Neogen stock news signals to limit their universe of possible portfolio assets.
  
Global Mycotoxin Testing Market Global Mycotoxin Testing Market Dublin, June 19, 2024 -- The Global Mycotoxin Testing Market Report by Type , Technology , Sample, Region - Forecast to 2029 report has been added to ResearchAndMarkets.coms offering.The global mycotoxin testing market is estimated at USD 1.6 billion in 2024 and is p

Read at finance.yahoo.com
Yahoo News
  

Neogen Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Neogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Neogen Fundamental Analysis

We analyze Neogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Neogen is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Neogen Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neogen stock to make a market-neutral strategy. Peer analysis of Neogen could also be used in its relative valuation, which is a method of valuing Neogen by comparing valuation metrics with similar companies.

Peers

Neogen Related Equities

MEDPMedpace Holdings   1.25   
0%
8.0%
QGENQiagen NV   0.61   
0%
4.0%
SHCSotera Health   0.53   
0%
3.0%
IQVIQVIA Holdings   0.29   
0%
1.0%
ICLRICON PLC   0.10   
0%
1.0%
SERASera Prognostics   0.37   
2.0%
0%
FONRFonar   1.18   
8.0%
0%
RDNTRadNet   1.42   
9.0%
0%
MYGNMyriad Genetics   4.12   
28.0%
0%
ACRSAclaris Therapeutics   5.52   
37.0%
0%
BNRBurning Rock   12.14   
82.0%
0%
XGNExagen   14.67   
100.0%
0%

Complementary Tools for Neogen Stock analysis

When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios